Benefits of Using Alpha-Stim to Complement TMS
Transcranial Magnetic Stimulation (TMS) primarily treats depression, but for many individuals, depression is not the only mental health issue going on.
- Depression–anxiety comorbidity is common. Estimates vary by cohort and method, with some reports suggesting up to a 60% overlap between the two conditions (National Alliance on Mental Illness)
- Clinical literature suggests a bidirectional relationship between anxiety and depression, with each linked to a higher risk of the other over time.
- Studies have shown that roughly 80% to 85% of patients with depression report insomnia, and similar to anxiety, if insomnia gets worse, so too can depression
- Research has also found that depressed individuals with insomnia may be less likely to respond to treatment than depressed individuals without insomnia.
Taken together, these points reflect that managing comorbid anxiety and insomnia in patients with depression offers a promising component of comprehensive care. This is driving enthusiasm for Alpha-Stim as a complementary tool with TMS, leveraging its FDA-cleared use for anxiety and insomnia, at-home convenience, and favorable tolerability to help support patient comfort, engagement, and attempt to achieve stronger long-term treatment outcomes.
Targeting Anxiety and Insomnia is Clinically Important for TMS Candidates
Why add Alpha-Stim to your mental health toolkit?
The short answer? To safely and effectively manage anxiety and insomnia alongside clinic-based care, including TMS, to improve patient experience and achieve stronger overall mental health outcomes.
Alpha-Stim does not compete with or replace TMS. It complements TMS by targeting additional, separate indications (anxiety and insomnia) using Cranial Electrical Stimulation (CES). Providers using TMS and Alpha-Stim could see improved TMS outcomes by addressing comorbid symptoms of anxiety linked to delayed or incomplete responses.
Plus, Alpha-Stim (unlike many other anxiety and insomnia treatments in the market) is heavily researched and FDA-cleared to treat anxiety and insomnia.2 Patients and providers also love that it’s easy and safe for patients to use at home alone, making ongoing insomnia and anxiety relief possible.3
Benefits of using Alpha-Stim in a TMS program:
- Address comorbid anxiety and insomnia that clinical literature suggests could contribute to reduced TMS effectiveness or adherence
- Keep patients engaged and supported during waitlists and between sessions
- Provide patients with an at-home neuromodulation option for long-term management of anxiety and insomnia symptoms
- Differentiate your practice as a full-spectrum neuromodulation center extending outside of the clinic walls and catering to the growing demand for in-home treatment
- Improve overall mental health and wellness, as well as sleep quality and duration
How Alpha-Stim Manages Anxiety Throughout the TMS Patient Journey
Alpha-Stim also provides TMS programs with a unique ability to begin treating patients before TMS by proactively addressing anxiety and insomnia at home.
See below for an outline of how easily Alpha-Stim integrates into the TMS patient journey:
- Pre-TMS: Support patients on waitlists by providing access to at-home neuromodulation solutions to offer relief from anxiety and insomnia symptoms.
- In-clinic: Reduce pre-procedural anxiety to enhance patient comfort prior to undergoing TMS.
- Between TMS Sessions: Management of anxiety and insomnia symptoms outside of the clinic.
- Post-TMS: Strengthen therapeutic alliance with patients post-discharge by offering continued non-pharmacological treatment for anxiety and insomnia.
Plus, utilizing Alpha-Stim before and after TMS supports continued patient engagement efforts, which give you a better view of patient results, progress, and how to adjust their treatment protocol.
Try Adding Alpha-Stim to Your TMS Program
If you’re curious about how Alpha-Stim could round out your treatment capabilities, contact our team today. We’ll have a representative come to your clinic to walk through how Alpha-Stim can enable you to address a wider range of mental health indications, including comorbid anxiety and insomnia, often seen in TMS candidates.
*Alpha-Stim is FDA cleared for anxiety, insomnia, and pain only, with approval for depression outside of the United States.
Sources:
- https://www.nami.org/education/the-comorbidity-of-anxiety-and-depression/
- https://psycnet.apa.org/record/2017-34943-001
- https://share.upmc.com/2020/10/sleep-affects-mood/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181883/
- 1. Hutton, Todd M et al. “The Anxiolytic and Antidepressant Effects of Transcranial Magnetic Stimulation in Patients With Anxious Depression.” The Journal of clinical psychiatry vol. 84,1 22m14571. 11 Jan. 2023, doi:10.4088/JCP.22m14571
- 2. Barclay, T.H. & Barclay, R.D. (2014). A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective Disorders, 164, 171-177.
- Park, Byeong Seon et al. “Comparison of the effects of cranial electrotherapy stimulation and midazolam as preoperative treatment in geriatric patients: A CONSORT-compliant randomized controlled trial.” Medicine vol. 101,35 (2022): e30336. doi:10.1097/MD.0000000000030336